Form 4: Synaptics Director Nelson Chan Boosts Stake

Synaptics Inc. Director Nelson Chan acquired 3,036 shares of common stock, increasing his beneficial ownership to 45,719 shares.

Summary

• Nelson Chan, a Director at Synaptics Inc. (SYNA), acquired 3,036 shares of common stock.
• The transaction occurred on November 3, 2025.
• The acquisition price was $0, indicating a grant of restricted stock units (RSUs).
• Following this transaction, Chan beneficially owns 45,719 shares of Synaptics common stock.
• The acquired shares are restricted stock units that will vest quarterly, with full vesting by November 3, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders if Chan is not re-elected.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if through a grant, generally indicates confidence in the company's future and aligns management interests with shareholders. It's a positive signal for corporate governance and insider alignment.

Positives

• Director Nelson Chan increased his beneficial ownership in Synaptics Inc. by 3,036 shares.
• The acquisition of shares, likely through an RSU grant, aligns the director's interests with long-term shareholder value.

Risks

• The vesting of restricted stock units is contingent on continued service and performance, and for a Director not standing for re-election, vesting may accelerate to the date of the Issuer's 2026 Annual Meeting of Stockholders.

Future Outlook

The restricted stock units granted to Director Nelson Chan are scheduled to vest quarterly, with full vesting expected by November 3, 2026, or earlier if he does not stand for re-election at the 2026 Annual Meeting of Stockholders.

Industry Context

Insider transactions, such as this RSU grant to a director, are common practice in the technology sector to incentivize long-term commitment and align management interests with shareholder returns. This type of compensation is a standard component of executive and director remuneration packages across the industry.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) to directors is a standard compensation practice across the technology industry, similar to companies like Apple, Microsoft, and Intel, which use equity awards to retain and incentivize key personnel.
• The vesting schedule, with quarterly vesting over approximately one year, is a common structure for director equity awards, aiming to provide ongoing alignment without excessively long lock-up periods.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholder value through equity ownership.

Next Steps

• Continued vesting of the 3,036 restricted stock units quarterly until fully vested on November 3, 2026.
• Potential acceleration of vesting if Director Chan does not stand for re-election at the 2026 Annual Meeting of Stockholders.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to a director, which is a standard compensation practice. While it indicates continued insider alignment, it does not present new fundamental information that would warrant a change in investment thesis or a strong buy/sell recommendation. Investors should continue to hold based on broader company fundamentals.

Keywords

Synaptics, SYNA, Nelson Chan, Form 4, Insider Trading, Director Stock Acquisition, Restricted Stock Units, RSU, Beneficial Ownership